Kelong Ma
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
Papers in
-
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 6
- Gut microbiota and health 6
- Cancer-related gene regulation 4
- Genetics 8
- Inflammatory Bowel Disease 8
- Co-authors
- Jingde Zhu (7 shared papers)Yinghua He (8 shared papers)Hongyu Zhang (7 shared papers)Hendrik G. Stunnenberg (1 shared paper)Anita Kaan (1 shared paper)Arie B. Brinkman (1 shared paper)Femke Simmer (1 shared paper)Jun Gu (4 shared papers)
- Journals
- Journal of Leukocyte Biology (2 papers)Medical Mycology (2 papers)Journal of Biological Chemistry (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Kelong Ma
41 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 415
- Molecular Biology 959
- Pharmacology 36
- Genetics 114
- Oncology 111
Countries citing papers authored by Kelong Ma
This map shows the geographic impact of Kelong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelong Ma more than expected).
Fields of papers citing papers by Kelong Ma
This network shows the impact of papers produced by Kelong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelong Ma. The network helps show where Kelong Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Kelong Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 187 | |
| 2 | 2011 | 162 | |
| 3 | 2011 | 125 | |
| 4 | 2011 | 95 | |
| 5 | 2011 | 94 | |
| 6 | 2014 | 62 | |
| 7 | 2012 | 55 | |
| 8 | 2011 | 54 | |
| 9 | 2009 | 47 | |
| 10 | 2013 | 38 | |
| 11 | 2019 | 32 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 28 | |
| 14 | 2020 | 23 | |
| 15 | 2020 | 22 | |
| 16 | 2009 | 19 | |
| 17 | 2022 | 19 | |
| 18 | 2020 | 16 | |
| 19 | 2013 | 14 | |
| 20 | 2021 | 14 |
About Kelong Ma
Kelong Ma is a scholar working on Molecular Biology, Genetics, Cancer Research, Infectious Diseases and Surgery, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (8 papers), Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (6 papers), Gut microbiota and health (6 papers), Antifungal resistance and susceptibility (5 papers), Cancer-related molecular mechanisms research (5 papers), Pharmacological Effects of Natural Compounds (5 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Cancer Research (415 citations), Molecular Biology (959 citations), Pharmacology (36 citations), Genetics (114 citations) and Oncology (111 citations). Kelong Ma has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Jingde Zhu, Yinghua He, Hongyu Zhang, Hendrik G. Stunnenberg, Anita Kaan, Arie B. Brinkman, Femke Simmer, Jun Gu, Xiaoying Luo and Shicheng Guo. Their work appears in journals such as Journal of Leukocyte Biology, Medical Mycology, Journal of Biological Chemistry, Journal of Cancer Research and Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.